BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200326T080000
DTEND;TZID=America/New_York:20200327T170000
DTSTAMP:20260429T051024
CREATED:20200102T212531Z
LAST-MODIFIED:20200102T212531Z
UID:7695-1585209600-1585328400@scienceinboston.com
SUMMARY:Women on Boards Getting On and Adding Value
DESCRIPTION:Program Overview \nProviding Women Executives with Direction\, Tools\, and Approaches for Attaining a Seat on Health Care and Related Industry Boards \nGender disparity on boards of directors is well recognized and documented\, whether in the for-profit\, non-profit\, or government sectors. In the United States\, fewer than 20% of corporate board directors are women. Nearly 80% of venture capital firms have never had a woman represent them on the board of one of their portfolio companies. Yet studies show that companies with women on their boards make decisions that better protect company value and performance. \nProfoundly accomplished and qualified women have an interest in attaining positions on boards of directors and then assuming leadership roles on these boards\, but may be unclear how to successfully secure these appointments. Women on Boards: Getting on and Adding Value will put you on a productive path towards attaining a governance position in health care by focusing on the strategies and competencies that will help you succeed at being a first-rate board member\, preparing you for the challenges you will face\, and providing direction\, tools\, and approaches for attaining a board seat. \nThis is a Must-attend Program for Women Seeking Board Positions \nThis program will feature faculty who are highly successful women board members and other experts in the field. You will join other high-performing\, accomplished\, and ambitious women who have already achieved much in their careers and who desire to take their talent\, leadership\, and executive skills to the next level by serving on boards in health care and related industries. As a participant\, you will also have the opportunity to develop a personalized action plan to seek and obtain a board directorship. \nThis highly interactive course will use case studies and experiential sessions to prepare you for directorship and start you on the path to being a sought-after candidate. You will expand your ability to evaluate board opportunities based on your own preferences and cultural fit\, learn to communicate effectively in the language of boards\, and gain critical knowledge and skills you will need to be effective. \nWomen on Boards of Directors \nOrganizations with women in leadership positions perform better than those that don’t. They surpass others in social responsiveness\, sustainability\, and financial performance. Recent evidence also indicates that companies with female board members are more successful than those without women\, a key concern for organizational competitiveness.1 As a participant in this program\, you will: \n\nLearn the essential legal\, regulatory\, and operating knowledge you will need to serve on boards of directors\nDevelop a deep understanding of your roles and responsibilities as an effective board member\nConnect with\, and learn from\, women who have achieved success as board members\nDevelop an individual action plan to seek and secure a position on a board\n\nCourse WebsiteHarvard T.H. Chan School of Public HealthHarvard T.H. Chan School of Public Health
URL:https://scienceinboston.com/event/women-on-boards-getting-on-and-adding-value/
LOCATION:Harvard T.H. Chan School of Public Health\, FXB Building 651 Huntington Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200326T080000
DTEND;TZID=America/New_York:20200327T170000
DTSTAMP:20260429T051024
CREATED:20200102T212531Z
LAST-MODIFIED:20200102T212531Z
UID:27435-1585209600-1585328400@scienceinboston.com
SUMMARY:Women on Boards Getting On and Adding Value
DESCRIPTION:Program Overview \nProviding Women Executives with Direction\, Tools\, and Approaches for Attaining a Seat on Health Care and Related Industry Boards \nGender disparity on boards of directors is well recognized and documented\, whether in the for-profit\, non-profit\, or government sectors. In the United States\, fewer than 20% of corporate board directors are women. Nearly 80% of venture capital firms have never had a woman represent them on the board of one of their portfolio companies. Yet studies show that companies with women on their boards make decisions that better protect company value and performance. \nProfoundly accomplished and qualified women have an interest in attaining positions on boards of directors and then assuming leadership roles on these boards\, but may be unclear how to successfully secure these appointments. Women on Boards: Getting on and Adding Value will put you on a productive path towards attaining a governance position in health care by focusing on the strategies and competencies that will help you succeed at being a first-rate board member\, preparing you for the challenges you will face\, and providing direction\, tools\, and approaches for attaining a board seat. \nThis is a Must-attend Program for Women Seeking Board Positions \nThis program will feature faculty who are highly successful women board members and other experts in the field. You will join other high-performing\, accomplished\, and ambitious women who have already achieved much in their careers and who desire to take their talent\, leadership\, and executive skills to the next level by serving on boards in health care and related industries. As a participant\, you will also have the opportunity to develop a personalized action plan to seek and obtain a board directorship. \nThis highly interactive course will use case studies and experiential sessions to prepare you for directorship and start you on the path to being a sought-after candidate. You will expand your ability to evaluate board opportunities based on your own preferences and cultural fit\, learn to communicate effectively in the language of boards\, and gain critical knowledge and skills you will need to be effective. \nWomen on Boards of Directors \nOrganizations with women in leadership positions perform better than those that don’t. They surpass others in social responsiveness\, sustainability\, and financial performance. Recent evidence also indicates that companies with female board members are more successful than those without women\, a key concern for organizational competitiveness.1 As a participant in this program\, you will: \n\nLearn the essential legal\, regulatory\, and operating knowledge you will need to serve on boards of directors\nDevelop a deep understanding of your roles and responsibilities as an effective board member\nConnect with\, and learn from\, women who have achieved success as board members\nDevelop an individual action plan to seek and secure a position on a board\n\nCourse WebsiteHarvard T.H. Chan School of Public HealthHarvard T.H. Chan School of Public Health
URL:https://scienceinboston.com/event/women-on-boards-getting-on-and-adding-value-2/
LOCATION:Harvard T.H. Chan School of Public Health\, FXB Building 651 Huntington Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200327T090000
DTEND;TZID=America/New_York:20200327T110000
DTSTAMP:20260429T051024
CREATED:20200323T181952Z
LAST-MODIFIED:20200323T181952Z
UID:8519-1585299600-1585306800@scienceinboston.com
SUMMARY:Debt\, Dignity\, and Health Care: Guaranteeing Health Rights and Universal Health Coverage
DESCRIPTION:Online Viewing\nIn light of the rapidly developing COVID-19 outbreaks\, Harvard University has restricted on-campus events. As a result\, we will not be allowing in-person attendance at this event. Instead\, the event will be available for viewing online. To ensure that you will receive access to the livestream and be kept up to date on any changes to the event\, register now. We will send out a link to the livestream of the event to all registrants three days before the conference. \nHosting events\, even ones that are largely virtual\, is a constantly moving target these days and we appreciate your patience and flexibility as we fine tune our approach. In the meantime\, we hope you all stay well. \nDescription\nEach year in low- and middle-income countries thousands of people are detained in hospitals for non-payment of medical bills\, despite the fact that such detention is a violation of national and international law. Hospital detention for nonpayment of bills disproportionately affects the most vulnerable people\, including post-partum women. \nIn the US\, medical debt manifests itself in other ways\, including bankruptcy\, litigation to garnish wages\, and foregone care.  In both contexts\, these scandals are the result of failures of financing\, priority-setting\, and legal oversight. \nWithout addressing these systemic issues\, a “human right to health care” will remain a hollow slogan\, as will political promises to achieve universal health coverage. \nThis event will feature Robert Yates of Chatham House\, which has conducted an in-depth investigation of the global phenomenon of hospital detentions. Additional panelists will address manifestations of predatory lending and surprise medical fees in the United States\, the ethical imperatives of financing and priority setting for UHC in general\, and the implications for thinking about health care as a human right. \nAgenda\n9:00 – 9:05am\, Welcome and Introduction\n\nAlicia Ely Yamin\, Senior Fellow in Global Health and Rights\, The Petrie-Flom Center for Health Law Policy\, Biotechnology\, and Bioethics\, Harvard Law School\n\n9:05 – 9:45am\, Keynote Address\n\nRobert Yates\, Director\, Global Health Programme and Executive Director\, Centre for Universal Health\, Chatham House\n\n9:45 – 10:30am\, Debt in the American Health Care System\n\nWendi C. Thomas\, Editor\, MLK50: Justice Through Journalism and investigative reporter of “Profiting from the Poor: Inside Memphis’ Debt Machine\,” which was produced in partnership with ProPublica.\nJay Hancock\, Senior Correspondent\, Kaiser Health News and contributor to KHN’s investigation of the University of Virginia Health System’s aggressive billing practices\n\n10:30 – 10:45am\, Closing Reflections\n\nAlicia Ely Yamin\, Senior Fellow in Global Health and Rights\, The Petrie-Flom Center for Health Law Policy\, Biotechnology\, and Bioethics\, Harvard Law School\n\nRegister\nThis event is free and can be viewed online by the public\, but registration is required. Register now!
URL:https://scienceinboston.com/event/debt-dignity-and-health-care-guaranteeing-health-rights-and-universal-health-coverage/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200327T090000
DTEND;TZID=America/New_York:20200327T110000
DTSTAMP:20260429T051024
CREATED:20200323T181952Z
LAST-MODIFIED:20200323T181952Z
UID:27441-1585299600-1585306800@scienceinboston.com
SUMMARY:Debt\, Dignity\, and Health Care: Guaranteeing Health Rights and Universal Health Coverage
DESCRIPTION:Online Viewing\nIn light of the rapidly developing COVID-19 outbreaks\, Harvard University has restricted on-campus events. As a result\, we will not be allowing in-person attendance at this event. Instead\, the event will be available for viewing online. To ensure that you will receive access to the livestream and be kept up to date on any changes to the event\, register now. We will send out a link to the livestream of the event to all registrants three days before the conference. \nHosting events\, even ones that are largely virtual\, is a constantly moving target these days and we appreciate your patience and flexibility as we fine tune our approach. In the meantime\, we hope you all stay well. \nDescription\nEach year in low- and middle-income countries thousands of people are detained in hospitals for non-payment of medical bills\, despite the fact that such detention is a violation of national and international law. Hospital detention for nonpayment of bills disproportionately affects the most vulnerable people\, including post-partum women. \nIn the US\, medical debt manifests itself in other ways\, including bankruptcy\, litigation to garnish wages\, and foregone care.  In both contexts\, these scandals are the result of failures of financing\, priority-setting\, and legal oversight. \nWithout addressing these systemic issues\, a “human right to health care” will remain a hollow slogan\, as will political promises to achieve universal health coverage. \nThis event will feature Robert Yates of Chatham House\, which has conducted an in-depth investigation of the global phenomenon of hospital detentions. Additional panelists will address manifestations of predatory lending and surprise medical fees in the United States\, the ethical imperatives of financing and priority setting for UHC in general\, and the implications for thinking about health care as a human right. \nAgenda\n9:00 – 9:05am\, Welcome and Introduction\n\nAlicia Ely Yamin\, Senior Fellow in Global Health and Rights\, The Petrie-Flom Center for Health Law Policy\, Biotechnology\, and Bioethics\, Harvard Law School\n\n9:05 – 9:45am\, Keynote Address\n\nRobert Yates\, Director\, Global Health Programme and Executive Director\, Centre for Universal Health\, Chatham House\n\n9:45 – 10:30am\, Debt in the American Health Care System\n\nWendi C. Thomas\, Editor\, MLK50: Justice Through Journalism and investigative reporter of “Profiting from the Poor: Inside Memphis’ Debt Machine\,” which was produced in partnership with ProPublica.\nJay Hancock\, Senior Correspondent\, Kaiser Health News and contributor to KHN’s investigation of the University of Virginia Health System’s aggressive billing practices\n\n10:30 – 10:45am\, Closing Reflections\n\nAlicia Ely Yamin\, Senior Fellow in Global Health and Rights\, The Petrie-Flom Center for Health Law Policy\, Biotechnology\, and Bioethics\, Harvard Law School\n\nRegister\nThis event is free and can be viewed online by the public\, but registration is required. Register now!
URL:https://scienceinboston.com/event/debt-dignity-and-health-care-guaranteeing-health-rights-and-universal-health-coverage-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200330T080000
DTEND;TZID=America/New_York:20200409T170000
DTSTAMP:20260429T051024
CREATED:20200102T213629Z
LAST-MODIFIED:20200102T213629Z
UID:7697-1585555200-1586451600@scienceinboston.com
SUMMARY:The International Leadership Development Program for Physicians
DESCRIPTION:Develop the knowledge and skills you need to effectively lead your health care organization. \nPhysicians are often selected for senior leadership positions based on clinical expertise. No matter the setting\, these expanded roles require knowledge of critical management skills and leadership practices\, which are not typically part of physician training. \nThis executive education program brings together a peer group of physician leaders from a variety of health care settings around the world who face similar challenges. Harvard experts and industry leaders provide focused leadership and management training\, ensuring participants are prepared to direct change and drive value within their organizations and communities. \nDuring this highly interactive course\, participants will engage with each other and expert faculty in small groups\, experiential activities\, and full-class discussions\, allowing for an open exchange of ideas to address the challenges inherent in creating a healthy population\, quality health care\, and maintaining cost effectiveness. \nAs a participant\, you will: \n\nDevelop a deeper awareness of your own leadership strengths and development opportunities\nEnhance your strategy\, negotiation\, conflict management\, peer and team management and other key leadership skills\nExpand your understanding of responsibilities and options as a manager of a  clinical department\, service\, or program and as a senior institutional leader\nLearn strategies and tactics to lower costs and improve operations while increasing quality and safety\nAdvance knowledge and skills in the art and science of improvement\, allowing each participant the opportunity to immediately apply the skills they learn to a selected improvement project during the program\nVisit and engage with change agents in high performing health care delivery organizations in the greater Boston area\nAll while innovating and developing new and better ways of delivering care to meet the needs of patients and employees\n\nYou will also have the opportunity to learn from the Harvard case-based style of learning\, which provides a deep understanding of how leadership concepts apply to everyday situations in settings around the world. \nImprove Health Care\, Experience\, and Value \nAs part of the program\, each participant will identify and develop a plan for an improvement project connected to her or his organization’s business plan. Each participant will identify a key area of change prior to the start of the program\, submit the idea to faculty for review\, and actively work on the project during the program and beyond. \nThe improvement project may be in any one of three categories: \n\nImproving quality of care and services\nReducing costs while maintaining or improving quality\nExpanding patient or customer satisfaction with the development of new services or innovative ways of providing existing services\n\nThroughout the program you will work with faculty and participant colleagues to refine and further develop your project\, so that you can implement the project when you return home. Whether you work at a public health delivery site\, a government agency\, or another setting\, this collaboration will enable you to move forward with an actionable plan to improve performance. \nThe design of this program allows participants to achieve results by immediately applying the skills they learn to everyday work experiences. This combination of theory applied to daily work makes the program unique and provides a foundation for making improvements long after the program is completed. \nHarvard faculty in the program will assist you before and during the program\, guiding you through the steps required for successful change. You will work with Harvard faculty and your peers to advance your implementation goals by applying learning from the classroom in the context of your home environment. \nLearn from Experts in the Field \nThis applied program is designed and led by Harvard Chan School faculty who are recognized experts in improving health care in diverse settings around the world. The faculty will work with you on how learnings are applicable and tailorable to your specific health care setting. You will leave this program with the tools and strategies to be a more effective manager and leader and to make a greater impact on executing successful change when you return home. Topics explored during this program include: \n\nEvidence-based decision making\nFinancial analysis and cost control\nGenerating and sustaining innovation\nLeadership\nCreating and managing change\nNegotiation\nTeam building and performance\nOrganizational strategy\nPatient safety and engagement\nQuality improvement methods and tools\n\nAs a participant\, you will visit a high performing health care delivery organization that serves a diverse population in the Greater Boston area. Through this visit\, you will meet with successful innovators to experience how highly effective leadership can improve care\, health\, and value. This is an unparalleled opportunity to discuss the issues you face as a health care leader with colleagues and experts who are meeting these challenges. \nCourse WebsiteHarvard T.H. Chan School of Public HealthHarvard T.H. Chan School of Public Health
URL:https://scienceinboston.com/event/the-international-leadership-development-program-for-physicians/
LOCATION:Harvard T.H. Chan School of Public Health\, FXB Building 651 Huntington Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200330T080000
DTEND;TZID=America/New_York:20200409T170000
DTSTAMP:20260429T051024
CREATED:20200102T213629Z
LAST-MODIFIED:20200102T213629Z
UID:27436-1585555200-1586451600@scienceinboston.com
SUMMARY:The International Leadership Development Program for Physicians
DESCRIPTION:Develop the knowledge and skills you need to effectively lead your health care organization. \nPhysicians are often selected for senior leadership positions based on clinical expertise. No matter the setting\, these expanded roles require knowledge of critical management skills and leadership practices\, which are not typically part of physician training. \nThis executive education program brings together a peer group of physician leaders from a variety of health care settings around the world who face similar challenges. Harvard experts and industry leaders provide focused leadership and management training\, ensuring participants are prepared to direct change and drive value within their organizations and communities. \nDuring this highly interactive course\, participants will engage with each other and expert faculty in small groups\, experiential activities\, and full-class discussions\, allowing for an open exchange of ideas to address the challenges inherent in creating a healthy population\, quality health care\, and maintaining cost effectiveness. \nAs a participant\, you will: \n\nDevelop a deeper awareness of your own leadership strengths and development opportunities\nEnhance your strategy\, negotiation\, conflict management\, peer and team management and other key leadership skills\nExpand your understanding of responsibilities and options as a manager of a  clinical department\, service\, or program and as a senior institutional leader\nLearn strategies and tactics to lower costs and improve operations while increasing quality and safety\nAdvance knowledge and skills in the art and science of improvement\, allowing each participant the opportunity to immediately apply the skills they learn to a selected improvement project during the program\nVisit and engage with change agents in high performing health care delivery organizations in the greater Boston area\nAll while innovating and developing new and better ways of delivering care to meet the needs of patients and employees\n\nYou will also have the opportunity to learn from the Harvard case-based style of learning\, which provides a deep understanding of how leadership concepts apply to everyday situations in settings around the world. \nImprove Health Care\, Experience\, and Value \nAs part of the program\, each participant will identify and develop a plan for an improvement project connected to her or his organization’s business plan. Each participant will identify a key area of change prior to the start of the program\, submit the idea to faculty for review\, and actively work on the project during the program and beyond. \nThe improvement project may be in any one of three categories: \n\nImproving quality of care and services\nReducing costs while maintaining or improving quality\nExpanding patient or customer satisfaction with the development of new services or innovative ways of providing existing services\n\nThroughout the program you will work with faculty and participant colleagues to refine and further develop your project\, so that you can implement the project when you return home. Whether you work at a public health delivery site\, a government agency\, or another setting\, this collaboration will enable you to move forward with an actionable plan to improve performance. \nThe design of this program allows participants to achieve results by immediately applying the skills they learn to everyday work experiences. This combination of theory applied to daily work makes the program unique and provides a foundation for making improvements long after the program is completed. \nHarvard faculty in the program will assist you before and during the program\, guiding you through the steps required for successful change. You will work with Harvard faculty and your peers to advance your implementation goals by applying learning from the classroom in the context of your home environment. \nLearn from Experts in the Field \nThis applied program is designed and led by Harvard Chan School faculty who are recognized experts in improving health care in diverse settings around the world. The faculty will work with you on how learnings are applicable and tailorable to your specific health care setting. You will leave this program with the tools and strategies to be a more effective manager and leader and to make a greater impact on executing successful change when you return home. Topics explored during this program include: \n\nEvidence-based decision making\nFinancial analysis and cost control\nGenerating and sustaining innovation\nLeadership\nCreating and managing change\nNegotiation\nTeam building and performance\nOrganizational strategy\nPatient safety and engagement\nQuality improvement methods and tools\n\nAs a participant\, you will visit a high performing health care delivery organization that serves a diverse population in the Greater Boston area. Through this visit\, you will meet with successful innovators to experience how highly effective leadership can improve care\, health\, and value. This is an unparalleled opportunity to discuss the issues you face as a health care leader with colleagues and experts who are meeting these challenges. \nCourse WebsiteHarvard T.H. Chan School of Public HealthHarvard T.H. Chan School of Public Health
URL:https://scienceinboston.com/event/the-international-leadership-development-program-for-physicians-2/
LOCATION:Harvard T.H. Chan School of Public Health\, FXB Building 651 Huntington Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200403T083000
DTEND;TZID=America/New_York:20200403T163000
DTSTAMP:20260429T051024
CREATED:20200323T182646Z
LAST-MODIFIED:20200323T182646Z
UID:8523-1585902600-1585931400@scienceinboston.com
SUMMARY:Autism Partnership Foundation 5th Annual Conference 2020 - LIVESTREAM EVENT
DESCRIPTION:Preserving Quality ABA and the Effective Implementation of Autism Treatment \nDistinguished experts in the field of Applied Behavior Analysis (ABA) and Autism Spectrum Disorder (ASD) join together for a day of education\, discussion\, and reflection \n  \nWHO SHOULD ATTEND? \n\nBehavior Analysts\n•Educators\n•   Psychologists\n•   Speech Language Pathologists\n•   Parents\n•   Anyone dedicated to ensuring children with ASD have access to quality treatment\n\n  \nCONTINUING EDUCATION \n  \nContinuing education is offered for: \n\nBACB (7 units\, type 2)  – 2 units of Ethics\n\nCOST \n  \n\n$150 – Registration\n\nRegistration includes of BACB CEUs \nRefunds can be requested up to 15 days prior to the event.  A $25 processing fee will be withheld. Once your login and password is emailed to you the week of the livestream event\, the registration is non-refundable. \nREGISTRATION \n  \nIf you are registering for BACB Continuing Education Units (CEus)\, have your certification number ready. You will need to enter it during the registration process. \nA day or two before the event\, each attendee will receive an email with their login information for the livestream. Once your login and password is emailed to you\, the registration is non-refundable. \n  \nMEET THE SPEAKERS \nWilliam Heward \nTitle: Next Year is Now \n  \nWilliam L. Heward\, Ed.D.\, BCBA-D\, is Professor Emeritus in the College of Education and Human Ecology at The Ohio State University. A Fellow and Past President of the Association for Behavior Analysis International\, Bill has been a Fulbright Scholar in Portugal\, a Visiting Professor of Psychology at Keio University in Tokyo and at the University of São Paulo\, and given lectures and workshops in 22 other countries. His publications include the books Applied Behavior Analysis(with John Cooper and Tim Heron)\, Sign Here: A Contracting Book for Children and Their Parents(with Jill Dardig)\, and Exceptional Children: An Introduction to Special Education(with Sheila Alber-Morgan and Moira Konrad)\,each of which has been translated into several foreign languages. Awards recognizing Bill’s contributions to behavior analysis include the Fred S. Keller Behavioral Education Award from the American Psychological Association’s Division 25\, the Ellen P. Reese Award for Communication of Behavioral Concepts from the Cambridge Center for Behavioral Studies\, and the Distinguished Psychology Department Alumnus Award from Western Michigan University. Bill’s research interests include “low-tech” methods for increasing the effectiveness of group instruction in inclusive classrooms. \n  \nDisclosure: \nWILLIAM HEWARD \nFINANCIAL: is employed by Ohio State University as a professor in the College of Education and Human Ecology.  Dr. Heward is a Fellow and Past President of the Association for Behavior Analysis International.  Dr. Heward will receive reimbursement of travel expenses for this conference. \nNON-FINANCIAL: Dr. Heward has published several books and peer-reviewed journals \n  \n  \nFred Volkmar \nTitle: Advances in Understanding the Social Nature of Autism \n  \nFred R. Volkmar\, M.D.\, is the Irving B. Harris Professor of Child Psychiatry\, Psychiatry\, Pediatrics\, and Psychology at Yale University\, Child Study Center and recently served for eight years as Director of the Center.  A graduate of the University of Illinois and Stanford\, Dr. Volkmar completed residency training in adult psychiatry and then a Fellowship in Child Psychiatry at the Yale University’s School of Medicine and has been there ever since.  He has dedicated his career to understanding and treating children with developmental disorders and is a leader in the field of autism research. He has served as a teacher and mentor to many trainees some of whom are now leaders in the field. Dr. Volkmar’s grants and publications run just short of 100 pages in his CV. He is editor of the Journal of Autism\, a gifted clinician and teacher and his contributions have greatly improved the lives of children suffering from developmental disorders and their families. \n  \n  \nDisclosure: \nFRED VOLKMAR \nFINANCIAL: is employed by Yale University as a professor of Child Psychiatry\, Psychiatry\, Pediatrics and Psychology.  Dr. Volkmar will receive reimbursement of travel expenses for this conference. \nNON-FINANCIAL:  Dr. Volkmar serves as a teacher and mentor to many leaders in the field and is the editor of the Journal of Autism. \n  \n  \nJonathan Tarbox \nTitle: Acceptance and Commitment Training inside Behavior Analysis: Ethics and Recent Developments \n  \nDr. Jonathan Tarbox is the program director of the Master of Science in Applied Behavior Analysis Program at the University of Southern California\, as well as director of Research at FirstSteps for Kids. Dr. Tarbox is the incoming editor-in-chief of the journal Behavior Analysis in Practice and serves on the editorial boards of several major scientific journals related to autism and behavior analysis. He has published four books on autism treatment and well over 70 peer-reviewed journal articles and chapters in scientific texts. His research focuses on behavioral interventions for teaching complex skills to individuals with autism. \n  \n  \nDisclosure: \nJONATHAN TARBOX \nFINANCIAL: is employed by the University of Southern California as the program director of the Applied Behavior Analysis Program. Dr. Tarbox is the incoming editor in chief of the journal Behavior Analysis in Practice.  Dr. Tarbox will receive reimbursement of travel expenses for this conference. \nNON-FINANCIAL:  Dr. Tarbox has published four books on autism treatment and written well over 70 peer reviewed journal articles. \n  \n  \nRachel Taylor \nTitle: Behavior Analysts in a Virtual Bar Talking About the Future \n  \nDr. Rachel Taylor (formerly Dr. Tarbox) has supported individuals diagnosed with neurodevelopmental disorders for more than 20 years. Dr. Taylor started her career working in several prestigious institutions including the New England Center for Children and the Kennedy Krieger Institute at Johns Hopkins Hospital. After earning her PhD she held numerous executive-level management positions in behavioral health agencies including Co-Director of Research and Development for the Center for Autism and Related Disorders (CARD)\, Founder and Director of CARD’s Specialized Outpatient Services\, and Chief Clinical Officer for Intercare Therapy\, Inc.. \n  \nDr. Taylor was also the founding Department Chair for the ABA Masters and PhD programs at The Chicago School of Professional Psychology Los Angeles and an Associate Faculty member in Psychology at California State University Los Angeles and Channel Islands. She has published numerous peer reviewed articles and her research is also featured in the seminal textbook Applied Behavior Analysis\, by Cooper\, Heron and Heward.\nIn addition to her research\, clinical and academic positions\, Dr. Taylor previously served on the Executive Council for the International Association for Behavior Analysis (ABAI). More recently\, she was named as an Advisor to the Cambridge Center for Behavioral Studies. Dr. Taylor also serves on Board of Directors for the California Association for Behavior Analysis (CalABA) as the 2020 Conference Chair. \n  \nHer current interests include 1) protecting against a potential divide between science and practice and 2) demonstrating how ABA produces socially significant improvements regardless of age or diagnosis. Dr. Taylor is especially proud of CABAs reputation for providing high-quality ABA services to adolescents and adults across settings (e.g. community-based and residential) and she is currently increasing her focus on helping other organizations to expand the scope of their ABA practice. \n  \n  \nDisclosure: \nRACHEL TAYLOR \nFINANCIAL: Dr. Taylor is the CEO of Center for Applied Behavior Analysis.   Dr. Taylor will receive reimbursement of travel expenses for this conference. \nNON-FINANCIAL:  Dr. Taylor serves on the Board of Directors for the California Association for Behavior Analysis (CalABA) and has published numerous peer-reviewed articles. \n  \nSteve Woolf \nTitle: Ethical Challenges in the Developing Business of Autism Treatment \n  \nDr. Woolf has been a BCBA/BCBA-D for over 16 years and is the President Butterfly Effects\, which is one of the largest home based ASD service providers in the nation. He regularly communicates with state officials at Department of Public Health\, Department of Developmental Services\, special education directors\, and state legislators on the funding and quality of ABA services. Dr. Woolf has authored publications and regularly presents ABA research at state\, national\, and international conferences. He has extensive experience providing treatment to children and adults with disabilities. He is the former president/founder of MassABA and eight year executive member on CTABA. He also served as the  ABAI Chapter leadership coordinator for three years. Dr. Woolf’s specialty areas include managing large scale home-based service delivery system\, practice ethics\, and licensure of behavior analysts. Dr. Woolf also has significant experience working with numerous health insurance providers relative to funding ABA-informed treatment.  He is currently one of the two Massachusetts Governor appointees to the Allied Mental Health and Human Services Professionals Licensure Board and the 2018 recipient of the MassABA distinguished service award. \n  \nDisclosure: \nSTEVE WOOLF \nFINANCIAL: is employed by Butterfly Effects as the President. He has authored publications and regularly presents ABA research at state\, national\, and international conferences. Dr. Woolf will receive reimbursement of travel expenses for this conference. \nNON-FINANCIAL:  Dr. Woolf is the former president and founder of MassABA and is a member of CTABA. He is currently one of two Massachusetts Governor appointees to the Allied Mental Health and Human Services Professionals Licensure Board. \n  \n  \nSarah Trautman \nTitle: Behavior Analysts in a Virtual Bar Talking About the Future \n  \nSarah has been in-love with Behavior Analysis since she took her first Intro to ABA Class at Gonzaga University in 1996. Sarah became a Board Certified Behavior Analyst in 2004 (she even took the exam using real paper and a pencil). Sarah started her own ABA Business\, STE Consultants\, in 2004. Over the 15-years that she owned STE Sarah grew her business to serve over 2\,500 clients throughout the West Coast. Sarah is the former President of the California Association for Behavior Analysis (CalABA) and was a founding Board Member for the Council of Autism Service Providers (CASP). Sarah has presented at over 20 professional conferences throughout the United States. Sarah has also presented and consulted internationally in Kenya\, Belize and Brazil. Sarah is very passionate about growing effective leaders and superb clinicians within our field. Currently Sarah is the Director of Development for the Behavior Analyst Leadership Council (BALC) and a Development Consultant for CalABA. In her spare time Sarah drinks too much coffee and not enough water. \n  \nDisclosure: \nSARAH TRAUTMAN \nFINANCIAL: is employed by STE Consultants where she serves as the owner.  She is the former President of the California Association for Behavior Analysis (CalABA). She has presented at over 20 professional conferences throughout the United States.  Ms. Trautman will receive reimbursement of travel expenses for this conference. \nNON-FINANCIAL:  Sarah Trautman is currently the Director of Development for the Behavior Analyst Leadership Council (BALC) and a Development Consultant for CalABA. \n  \nHave questions about Autism Partnership Foundation 5th Annual Conference 2020 – LIVESTREAM EVENT? Contact Autism Partnership Foundation
URL:https://scienceinboston.com/event/autism-partnership-foundation-5th-annual-conference-2020-livestream-event/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200403T083000
DTEND;TZID=America/New_York:20200403T163000
DTSTAMP:20260429T051024
CREATED:20200323T182646Z
LAST-MODIFIED:20200323T182646Z
UID:27443-1585902600-1585931400@scienceinboston.com
SUMMARY:Autism Partnership Foundation 5th Annual Conference 2020 - LIVESTREAM EVENT
DESCRIPTION:Preserving Quality ABA and the Effective Implementation of Autism Treatment \nDistinguished experts in the field of Applied Behavior Analysis (ABA) and Autism Spectrum Disorder (ASD) join together for a day of education\, discussion\, and reflection \n  \nWHO SHOULD ATTEND? \n\nBehavior Analysts\n•Educators\n•   Psychologists\n•   Speech Language Pathologists\n•   Parents\n•   Anyone dedicated to ensuring children with ASD have access to quality treatment\n\n  \nCONTINUING EDUCATION \n  \nContinuing education is offered for: \n\nBACB (7 units\, type 2)  – 2 units of Ethics\n\nCOST \n  \n\n$150 – Registration\n\nRegistration includes of BACB CEUs \nRefunds can be requested up to 15 days prior to the event.  A $25 processing fee will be withheld. Once your login and password is emailed to you the week of the livestream event\, the registration is non-refundable. \nREGISTRATION \n  \nIf you are registering for BACB Continuing Education Units (CEus)\, have your certification number ready. You will need to enter it during the registration process. \nA day or two before the event\, each attendee will receive an email with their login information for the livestream. Once your login and password is emailed to you\, the registration is non-refundable. \n  \nMEET THE SPEAKERS \nWilliam Heward \nTitle: Next Year is Now \n  \nWilliam L. Heward\, Ed.D.\, BCBA-D\, is Professor Emeritus in the College of Education and Human Ecology at The Ohio State University. A Fellow and Past President of the Association for Behavior Analysis International\, Bill has been a Fulbright Scholar in Portugal\, a Visiting Professor of Psychology at Keio University in Tokyo and at the University of São Paulo\, and given lectures and workshops in 22 other countries. His publications include the books Applied Behavior Analysis(with John Cooper and Tim Heron)\, Sign Here: A Contracting Book for Children and Their Parents(with Jill Dardig)\, and Exceptional Children: An Introduction to Special Education(with Sheila Alber-Morgan and Moira Konrad)\,each of which has been translated into several foreign languages. Awards recognizing Bill’s contributions to behavior analysis include the Fred S. Keller Behavioral Education Award from the American Psychological Association’s Division 25\, the Ellen P. Reese Award for Communication of Behavioral Concepts from the Cambridge Center for Behavioral Studies\, and the Distinguished Psychology Department Alumnus Award from Western Michigan University. Bill’s research interests include “low-tech” methods for increasing the effectiveness of group instruction in inclusive classrooms. \n  \nDisclosure: \nWILLIAM HEWARD \nFINANCIAL: is employed by Ohio State University as a professor in the College of Education and Human Ecology.  Dr. Heward is a Fellow and Past President of the Association for Behavior Analysis International.  Dr. Heward will receive reimbursement of travel expenses for this conference. \nNON-FINANCIAL: Dr. Heward has published several books and peer-reviewed journals \n  \n  \nFred Volkmar \nTitle: Advances in Understanding the Social Nature of Autism \n  \nFred R. Volkmar\, M.D.\, is the Irving B. Harris Professor of Child Psychiatry\, Psychiatry\, Pediatrics\, and Psychology at Yale University\, Child Study Center and recently served for eight years as Director of the Center.  A graduate of the University of Illinois and Stanford\, Dr. Volkmar completed residency training in adult psychiatry and then a Fellowship in Child Psychiatry at the Yale University’s School of Medicine and has been there ever since.  He has dedicated his career to understanding and treating children with developmental disorders and is a leader in the field of autism research. He has served as a teacher and mentor to many trainees some of whom are now leaders in the field. Dr. Volkmar’s grants and publications run just short of 100 pages in his CV. He is editor of the Journal of Autism\, a gifted clinician and teacher and his contributions have greatly improved the lives of children suffering from developmental disorders and their families. \n  \n  \nDisclosure: \nFRED VOLKMAR \nFINANCIAL: is employed by Yale University as a professor of Child Psychiatry\, Psychiatry\, Pediatrics and Psychology.  Dr. Volkmar will receive reimbursement of travel expenses for this conference. \nNON-FINANCIAL:  Dr. Volkmar serves as a teacher and mentor to many leaders in the field and is the editor of the Journal of Autism. \n  \n  \nJonathan Tarbox \nTitle: Acceptance and Commitment Training inside Behavior Analysis: Ethics and Recent Developments \n  \nDr. Jonathan Tarbox is the program director of the Master of Science in Applied Behavior Analysis Program at the University of Southern California\, as well as director of Research at FirstSteps for Kids. Dr. Tarbox is the incoming editor-in-chief of the journal Behavior Analysis in Practice and serves on the editorial boards of several major scientific journals related to autism and behavior analysis. He has published four books on autism treatment and well over 70 peer-reviewed journal articles and chapters in scientific texts. His research focuses on behavioral interventions for teaching complex skills to individuals with autism. \n  \n  \nDisclosure: \nJONATHAN TARBOX \nFINANCIAL: is employed by the University of Southern California as the program director of the Applied Behavior Analysis Program. Dr. Tarbox is the incoming editor in chief of the journal Behavior Analysis in Practice.  Dr. Tarbox will receive reimbursement of travel expenses for this conference. \nNON-FINANCIAL:  Dr. Tarbox has published four books on autism treatment and written well over 70 peer reviewed journal articles. \n  \n  \nRachel Taylor \nTitle: Behavior Analysts in a Virtual Bar Talking About the Future \n  \nDr. Rachel Taylor (formerly Dr. Tarbox) has supported individuals diagnosed with neurodevelopmental disorders for more than 20 years. Dr. Taylor started her career working in several prestigious institutions including the New England Center for Children and the Kennedy Krieger Institute at Johns Hopkins Hospital. After earning her PhD she held numerous executive-level management positions in behavioral health agencies including Co-Director of Research and Development for the Center for Autism and Related Disorders (CARD)\, Founder and Director of CARD’s Specialized Outpatient Services\, and Chief Clinical Officer for Intercare Therapy\, Inc.. \n  \nDr. Taylor was also the founding Department Chair for the ABA Masters and PhD programs at The Chicago School of Professional Psychology Los Angeles and an Associate Faculty member in Psychology at California State University Los Angeles and Channel Islands. She has published numerous peer reviewed articles and her research is also featured in the seminal textbook Applied Behavior Analysis\, by Cooper\, Heron and Heward.\nIn addition to her research\, clinical and academic positions\, Dr. Taylor previously served on the Executive Council for the International Association for Behavior Analysis (ABAI). More recently\, she was named as an Advisor to the Cambridge Center for Behavioral Studies. Dr. Taylor also serves on Board of Directors for the California Association for Behavior Analysis (CalABA) as the 2020 Conference Chair. \n  \nHer current interests include 1) protecting against a potential divide between science and practice and 2) demonstrating how ABA produces socially significant improvements regardless of age or diagnosis. Dr. Taylor is especially proud of CABAs reputation for providing high-quality ABA services to adolescents and adults across settings (e.g. community-based and residential) and she is currently increasing her focus on helping other organizations to expand the scope of their ABA practice. \n  \n  \nDisclosure: \nRACHEL TAYLOR \nFINANCIAL: Dr. Taylor is the CEO of Center for Applied Behavior Analysis.   Dr. Taylor will receive reimbursement of travel expenses for this conference. \nNON-FINANCIAL:  Dr. Taylor serves on the Board of Directors for the California Association for Behavior Analysis (CalABA) and has published numerous peer-reviewed articles. \n  \nSteve Woolf \nTitle: Ethical Challenges in the Developing Business of Autism Treatment \n  \nDr. Woolf has been a BCBA/BCBA-D for over 16 years and is the President Butterfly Effects\, which is one of the largest home based ASD service providers in the nation. He regularly communicates with state officials at Department of Public Health\, Department of Developmental Services\, special education directors\, and state legislators on the funding and quality of ABA services. Dr. Woolf has authored publications and regularly presents ABA research at state\, national\, and international conferences. He has extensive experience providing treatment to children and adults with disabilities. He is the former president/founder of MassABA and eight year executive member on CTABA. He also served as the  ABAI Chapter leadership coordinator for three years. Dr. Woolf’s specialty areas include managing large scale home-based service delivery system\, practice ethics\, and licensure of behavior analysts. Dr. Woolf also has significant experience working with numerous health insurance providers relative to funding ABA-informed treatment.  He is currently one of the two Massachusetts Governor appointees to the Allied Mental Health and Human Services Professionals Licensure Board and the 2018 recipient of the MassABA distinguished service award. \n  \nDisclosure: \nSTEVE WOOLF \nFINANCIAL: is employed by Butterfly Effects as the President. He has authored publications and regularly presents ABA research at state\, national\, and international conferences. Dr. Woolf will receive reimbursement of travel expenses for this conference. \nNON-FINANCIAL:  Dr. Woolf is the former president and founder of MassABA and is a member of CTABA. He is currently one of two Massachusetts Governor appointees to the Allied Mental Health and Human Services Professionals Licensure Board. \n  \n  \nSarah Trautman \nTitle: Behavior Analysts in a Virtual Bar Talking About the Future \n  \nSarah has been in-love with Behavior Analysis since she took her first Intro to ABA Class at Gonzaga University in 1996. Sarah became a Board Certified Behavior Analyst in 2004 (she even took the exam using real paper and a pencil). Sarah started her own ABA Business\, STE Consultants\, in 2004. Over the 15-years that she owned STE Sarah grew her business to serve over 2\,500 clients throughout the West Coast. Sarah is the former President of the California Association for Behavior Analysis (CalABA) and was a founding Board Member for the Council of Autism Service Providers (CASP). Sarah has presented at over 20 professional conferences throughout the United States. Sarah has also presented and consulted internationally in Kenya\, Belize and Brazil. Sarah is very passionate about growing effective leaders and superb clinicians within our field. Currently Sarah is the Director of Development for the Behavior Analyst Leadership Council (BALC) and a Development Consultant for CalABA. In her spare time Sarah drinks too much coffee and not enough water. \n  \nDisclosure: \nSARAH TRAUTMAN \nFINANCIAL: is employed by STE Consultants where she serves as the owner.  She is the former President of the California Association for Behavior Analysis (CalABA). She has presented at over 20 professional conferences throughout the United States.  Ms. Trautman will receive reimbursement of travel expenses for this conference. \nNON-FINANCIAL:  Sarah Trautman is currently the Director of Development for the Behavior Analyst Leadership Council (BALC) and a Development Consultant for CalABA. \n  \nHave questions about Autism Partnership Foundation 5th Annual Conference 2020 – LIVESTREAM EVENT? Contact Autism Partnership Foundation
URL:https://scienceinboston.com/event/autism-partnership-foundation-5th-annual-conference-2020-livestream-event-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200405T133000
DTEND;TZID=America/Vancouver:20200405T143000
DTSTAMP:20260429T051024
CREATED:20200427T204129Z
LAST-MODIFIED:20200427T204129Z
UID:8883-1586093400-1586097000@scienceinboston.com
SUMMARY:Innovation and Biotech in the Time of COVID-19: Testing Strategies
DESCRIPTION:Join LabCentral on Tuesday\, May 5 for a new episode of our series focused on innovation and biotech in the time of COVID-19.\n\n\n\n\n\n\nAbout this Event\n\n\nThis webinar series will feature biotech industry leaders\, experts\, and entrepreneurs discussing COVID-19 and its impact on innovation. \nIn our fourth panel\, hear from companies working on testing. They’ll detail current efforts & hurdles to rapidly expand efforts. \nWe hope to help you see a few steps further into the future and enjoy some realistic optimism for the next few months! \nOur webinar will be hosted on YouTube Live. Registrants will receive the link in an email shortly before broadcast. \nContact emulcahy@labcentral.org with questions.
URL:https://scienceinboston.com/event/innovation-and-biotech-in-the-time-of-covid-19-testing-strategies/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/04/Lab-Central-May-5-webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200405T133000
DTEND;TZID=America/Vancouver:20200405T143000
DTSTAMP:20260429T051024
CREATED:20200427T204129Z
LAST-MODIFIED:20200427T204129Z
UID:27475-1586093400-1586097000@scienceinboston.com
SUMMARY:Innovation and Biotech in the Time of COVID-19: Testing Strategies
DESCRIPTION:Join LabCentral on Tuesday\, May 5 for a new episode of our series focused on innovation and biotech in the time of COVID-19.\n\n\n\n\n\n\nAbout this Event\n\n\nThis webinar series will feature biotech industry leaders\, experts\, and entrepreneurs discussing COVID-19 and its impact on innovation. \nIn our fourth panel\, hear from companies working on testing. They’ll detail current efforts & hurdles to rapidly expand efforts. \nWe hope to help you see a few steps further into the future and enjoy some realistic optimism for the next few months! \nOur webinar will be hosted on YouTube Live. Registrants will receive the link in an email shortly before broadcast. \nContact emulcahy@labcentral.org with questions.
URL:https://scienceinboston.com/event/innovation-and-biotech-in-the-time-of-covid-19-testing-strategies-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/04/Lab-Central-May-5-webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200407
DTEND;VALUE=DATE:20200408
DTSTAMP:20260429T051024
CREATED:20200121T225113Z
LAST-MODIFIED:20200121T225113Z
UID:7778-1586217600-1586303999@scienceinboston.com
SUMMARY:HMX Pro Immunology - Immuno-oncology
DESCRIPTION:Learn how the immune system is being harnessed to improve cancer treatment in a new online course. \nHMX Pro online courses are designed to help busy professionals get up to speed on the latest advances in medical science. Each course is taught by Harvard Medical School faculty and include detailed animations and illustrations\, real-life scenarios\, and clinical videos that demonstrate the relevance of what you’re learning – with real patient interactions and cutting-edge treatments. \nBuild your science knowledge and learn what’s behind today’s health care innovations – while having the opportunity to earn a certificate from Harvard Medical School. \nHMX Pro Immunology – Immuno-oncology is an advanced course that covers topics including tumor immunology\, checkpoint blockade therapy\, CAR T cell therapy\, and more. \nThe next course period runs from April 7 – June 19\, 2020. \nApplications are due by March 17. Individual course tuition is $800.
URL:https://scienceinboston.com/event/hmx-pro-immunology-immuno-oncology/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2020/01/HMX_CancerAnimTreatment_fb.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200407
DTEND;VALUE=DATE:20200408
DTSTAMP:20260429T051024
CREATED:20200121T225113Z
LAST-MODIFIED:20200121T225113Z
UID:27438-1586217600-1586303999@scienceinboston.com
SUMMARY:HMX Pro Immunology - Immuno-oncology
DESCRIPTION:Learn how the immune system is being harnessed to improve cancer treatment in a new online course. \nHMX Pro online courses are designed to help busy professionals get up to speed on the latest advances in medical science. Each course is taught by Harvard Medical School faculty and include detailed animations and illustrations\, real-life scenarios\, and clinical videos that demonstrate the relevance of what you’re learning – with real patient interactions and cutting-edge treatments. \nBuild your science knowledge and learn what’s behind today’s health care innovations – while having the opportunity to earn a certificate from Harvard Medical School. \nHMX Pro Immunology – Immuno-oncology is an advanced course that covers topics including tumor immunology\, checkpoint blockade therapy\, CAR T cell therapy\, and more. \nThe next course period runs from April 7 – June 19\, 2020. \nApplications are due by March 17. Individual course tuition is $800.
URL:https://scienceinboston.com/event/hmx-pro-immunology-immuno-oncology-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2020/01/HMX_CancerAnimTreatment_fb.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200407
DTEND;VALUE=DATE:20200408
DTSTAMP:20260429T051024
CREATED:20200121T225140Z
LAST-MODIFIED:20200121T225140Z
UID:7776-1586217600-1586303999@scienceinboston.com
SUMMARY:HMX Pro Genetics - Cancer Genomics and Precision Oncology
DESCRIPTION:HMX Pro online courses are designed to help busy professionals get up to speed on the latest advances in medical science. Each course is taught by Harvard Medical School faculty and include detailed animations and illustrations\, real-life scenarios\, and clinical videos that demonstrate the relevance of what you’re learning – with real patient interactions and cutting-edge treatments. \nBuild your science knowledge and learn what’s behind today’s health care innovations – while having the opportunity to earn a certificate from Harvard Medical School. \nHMX Pro Genetics – Cancer Genomics and Precision Oncology is an advanced course that covers topics including cancer mutations\, tumor sequencing\, cancer therapeutics\, and more. \nThe next course period runs from April 7 – June 19\, 2020. \nApplications are due by March 17. Individual course tuition is $800.
URL:https://scienceinboston.com/event/hmx-pro-genetics-cancer-genomics-and-precision-oncology/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2020/01/HMX_TumorSeqGraph_fb.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200407
DTEND;VALUE=DATE:20200408
DTSTAMP:20260429T051024
CREATED:20200121T225140Z
LAST-MODIFIED:20200121T225140Z
UID:27437-1586217600-1586303999@scienceinboston.com
SUMMARY:HMX Pro Genetics - Cancer Genomics and Precision Oncology
DESCRIPTION:HMX Pro online courses are designed to help busy professionals get up to speed on the latest advances in medical science. Each course is taught by Harvard Medical School faculty and include detailed animations and illustrations\, real-life scenarios\, and clinical videos that demonstrate the relevance of what you’re learning – with real patient interactions and cutting-edge treatments. \nBuild your science knowledge and learn what’s behind today’s health care innovations – while having the opportunity to earn a certificate from Harvard Medical School. \nHMX Pro Genetics – Cancer Genomics and Precision Oncology is an advanced course that covers topics including cancer mutations\, tumor sequencing\, cancer therapeutics\, and more. \nThe next course period runs from April 7 – June 19\, 2020. \nApplications are due by March 17. Individual course tuition is $800.
URL:https://scienceinboston.com/event/hmx-pro-genetics-cancer-genomics-and-precision-oncology-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2020/01/HMX_TumorSeqGraph_fb.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200407T080000
DTEND;TZID=America/New_York:20200407T090000
DTSTAMP:20260429T051024
CREATED:20200323T182247Z
LAST-MODIFIED:20200323T182247Z
UID:8521-1586246400-1586250000@scienceinboston.com
SUMMARY:Grand Rounds: Disentangling the Links between Emotional Stress and Cardiovascular Disease
DESCRIPTION:Presenter: Ahmed Tawakol\, MD\nCo-Director\, Cardiovascular Imaging Research Center\, Massachusetts General Hospital \nDr Tawakol graduated from Stanford Medical School and did his Medical Residency and Cardiovascular Diseases Fellowship at Brigham and Women’s Hospital. He subsequently completed training in Nuclear Cardiology at Massachusetts General Hospital\, after which he joined the Cardiology Division staff. His clinical focus is in nuclear cardiology and general cardiology\, with a special focus on the identification of patients at highest risk for atherothrombotic event. \nDr Tawakol’s research interest is in imaging of atherosclerosis. His work has focused on developing novel diagnostic approaches and novel treatment strategies for atherosclerosis. To that end\, Dr Tawakol has developed and validated molecular methods to characterize atherosclerotic plaques\, and has made seminal observations validating the use of FDG-PET imaging for the measurement of atherosclerotic plaque inflammation. Currently\, he is leading several multi-center trials to evaluate interventions targeting plaque inflammation and is evaluating the potential clinical role of vascular PET imaging for improving the identification of patients at highest risk for atherothrombotic events. \nEvent Details\nDate/Time: Tuesday\,  April 7 | 8:00am – 9:00am (followed by coffee hour\, 9:00am – 10:00am)\nVenue: Bornstein Family Amphitheater\, Brigham and Women’s Hospital\, 45 Francis St. Boston\, MA\nCost: Free. CME credit available (for in-person and virtual attendance).\nDownload Flier\nSee full schedule \nLive Stream              \n1) If you DO NOT wish to request CME credit for virtual attendance\, view the live stream here.\n2) If you DO want to request CME credit for virtual participation\, to be eligible\, send an email between 8:00-8:30am on Tuesday\, Mar. 3rd with your full name\, degree and organization to jcantlin@bwh.harvard.edu. \nSubmit online questions via Twitter: @HMSOsherCenter (#TawakolApr7)\nTrouble Shooting: If you have trouble with the live stream please email: BWHWebcastTroubleShooting@partners.org
URL:https://scienceinboston.com/event/grand-rounds-disentangling-the-links-between-emotional-stress-and-cardiovascular-disease/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200407T080000
DTEND;TZID=America/New_York:20200407T090000
DTSTAMP:20260429T051024
CREATED:20200323T182247Z
LAST-MODIFIED:20200323T182247Z
UID:27442-1586246400-1586250000@scienceinboston.com
SUMMARY:Grand Rounds: Disentangling the Links between Emotional Stress and Cardiovascular Disease
DESCRIPTION:Presenter: Ahmed Tawakol\, MD\nCo-Director\, Cardiovascular Imaging Research Center\, Massachusetts General Hospital \nDr Tawakol graduated from Stanford Medical School and did his Medical Residency and Cardiovascular Diseases Fellowship at Brigham and Women’s Hospital. He subsequently completed training in Nuclear Cardiology at Massachusetts General Hospital\, after which he joined the Cardiology Division staff. His clinical focus is in nuclear cardiology and general cardiology\, with a special focus on the identification of patients at highest risk for atherothrombotic event. \nDr Tawakol’s research interest is in imaging of atherosclerosis. His work has focused on developing novel diagnostic approaches and novel treatment strategies for atherosclerosis. To that end\, Dr Tawakol has developed and validated molecular methods to characterize atherosclerotic plaques\, and has made seminal observations validating the use of FDG-PET imaging for the measurement of atherosclerotic plaque inflammation. Currently\, he is leading several multi-center trials to evaluate interventions targeting plaque inflammation and is evaluating the potential clinical role of vascular PET imaging for improving the identification of patients at highest risk for atherothrombotic events. \nEvent Details\nDate/Time: Tuesday\,  April 7 | 8:00am – 9:00am (followed by coffee hour\, 9:00am – 10:00am)\nVenue: Bornstein Family Amphitheater\, Brigham and Women’s Hospital\, 45 Francis St. Boston\, MA\nCost: Free. CME credit available (for in-person and virtual attendance).\nDownload Flier\nSee full schedule \nLive Stream              \n1) If you DO NOT wish to request CME credit for virtual attendance\, view the live stream here.\n2) If you DO want to request CME credit for virtual participation\, to be eligible\, send an email between 8:00-8:30am on Tuesday\, Mar. 3rd with your full name\, degree and organization to jcantlin@bwh.harvard.edu. \nSubmit online questions via Twitter: @HMSOsherCenter (#TawakolApr7)\nTrouble Shooting: If you have trouble with the live stream please email: BWHWebcastTroubleShooting@partners.org
URL:https://scienceinboston.com/event/grand-rounds-disentangling-the-links-between-emotional-stress-and-cardiovascular-disease-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200414T093000
DTEND;TZID=America/Vancouver:20200417T170000
DTSTAMP:20260429T051024
CREATED:20200413T184117Z
LAST-MODIFIED:20200413T184213Z
UID:8660-1586856600-1587142800@scienceinboston.com
SUMMARY:Open Data Science Conference
DESCRIPTION:ODSC East 2020 is one of the largest applied data science conferences in the world. Speakers include core contributors to many open source libraries and languages. Attend ODSC East 2020 and learn the latest AI & data science topics\, tools\, and languages from some of the best and brightest minds in the field.
URL:https://scienceinboston.com/event/open-data-science-conference/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200414T093000
DTEND;TZID=America/Vancouver:20200417T170000
DTSTAMP:20260429T051024
CREATED:20200413T184117Z
LAST-MODIFIED:20200413T184117Z
UID:27448-1586856600-1587142800@scienceinboston.com
SUMMARY:Open Data Science Conference
DESCRIPTION:ODSC East 2020 is one of the largest applied data science conferences in the world. Speakers include core contributors to many open source libraries and languages. Attend ODSC East 2020 and learn the latest AI & data science topics\, tools\, and languages from some of the best and brightest minds in the field.
URL:https://scienceinboston.com/event/open-data-science-conference-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200415T090000
DTEND;TZID=America/Vancouver:20200415T100000
DTSTAMP:20260429T051024
CREATED:20200330T174402Z
LAST-MODIFIED:20200330T174814Z
UID:8569-1586941200-1586944800@scienceinboston.com
SUMMARY:Webinar: The Modern Mentor
DESCRIPTION:Mentorship has transformative power. In today’s business world\, it has proven to be a critical element of success by getting people in positions of influence actively supporting\, sponsoring and guiding the careers of women as they progress through their careers\, particularly at pivotal decision points. However\, asking someone to mentor you and managing that relationship could be at times nerve-wracking. \nWCT is excited to offer a webinar that will help mentors and mentees achieve the most from any mentorship engagement. Fiona Gao\, a global marketing leader\, and Angela Brown\, President and CEO of Moneris\, recently participated in the WCT Protégé Project. Based on their experience\, they have released a white paper entitled “The Modern Mentor: Reimagining the Interconnectedness of Women in Business\,” which provides excellent advice for those in a mentorship or sponsorship relationship. \nDate: April 15\, 2020\nTime: 9am-10am PST\nRegister: here
URL:https://scienceinboston.com/event/webinar-the-modern-mentor/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200415T090000
DTEND;TZID=America/Vancouver:20200415T100000
DTSTAMP:20260429T051024
CREATED:20200330T174402Z
LAST-MODIFIED:20200330T174402Z
UID:27444-1586941200-1586944800@scienceinboston.com
SUMMARY:Webinar: The Modern Mentor
DESCRIPTION:Mentorship has transformative power. In today’s business world\, it has proven to be a critical element of success by getting people in positions of influence actively supporting\, sponsoring and guiding the careers of women as they progress through their careers\, particularly at pivotal decision points. However\, asking someone to mentor you and managing that relationship could be at times nerve-wracking. \nWCT is excited to offer a webinar that will help mentors and mentees achieve the most from any mentorship engagement. Fiona Gao\, a global marketing leader\, and Angela Brown\, President and CEO of Moneris\, recently participated in the WCT Protégé Project. Based on their experience\, they have released a white paper entitled “The Modern Mentor: Reimagining the Interconnectedness of Women in Business\,” which provides excellent advice for those in a mentorship or sponsorship relationship. \nDate: April 15\, 2020\nTime: 9am-10am PST\nRegister: here
URL:https://scienceinboston.com/event/webinar-the-modern-mentor-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T150000
DTEND;TZID=America/Vancouver:20200420T163000
DTSTAMP:20260429T051024
CREATED:20200417T210111Z
LAST-MODIFIED:20200417T210111Z
UID:8769-1587394800-1587400200@scienceinboston.com
SUMMARY:Responding to COVID-19: Opportunities for All Researchers to Engage
DESCRIPTION:Right now\, all eyes are on an urgent science issue and its effects on our society. While everyone has a role to play in reducing the spread of the virus\, scientists have unique opportunities to respond to the crisis in impactful ways. For example\, some scientists might volunteer their lab or data analysis skills. Regardless of discipline\, researchers may find opportunities to pivot their research agenda to address timely and relevant questions. And others might serve as voices for science to amplify evidence\, reduce the spread of misinformation\, and advocate for science-informed approaches to managing the pandemic. This online panel discussion will include researchers from different disciplines who will share ideas for scientists looking to respond in the current moment.
URL:https://scienceinboston.com/event/responding-to-covid-19-opportunities-for-all-researchers-to-engage/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200420T150000
DTEND;TZID=America/Vancouver:20200420T163000
DTSTAMP:20260429T051024
CREATED:20200417T210111Z
LAST-MODIFIED:20200417T210111Z
UID:27467-1587394800-1587400200@scienceinboston.com
SUMMARY:Responding to COVID-19: Opportunities for All Researchers to Engage
DESCRIPTION:Right now\, all eyes are on an urgent science issue and its effects on our society. While everyone has a role to play in reducing the spread of the virus\, scientists have unique opportunities to respond to the crisis in impactful ways. For example\, some scientists might volunteer their lab or data analysis skills. Regardless of discipline\, researchers may find opportunities to pivot their research agenda to address timely and relevant questions. And others might serve as voices for science to amplify evidence\, reduce the spread of misinformation\, and advocate for science-informed approaches to managing the pandemic. This online panel discussion will include researchers from different disciplines who will share ideas for scientists looking to respond in the current moment.
URL:https://scienceinboston.com/event/responding-to-covid-19-opportunities-for-all-researchers-to-engage-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200421T110000
DTEND;TZID=America/New_York:20200421T120000
DTSTAMP:20260429T051024
CREATED:20200417T172405Z
LAST-MODIFIED:20200417T172405Z
UID:8737-1587466800-1587470400@scienceinboston.com
SUMMARY:COVID-19: Community Conversations - Boston University
DESCRIPTION:Join Dean Sandro Galea online for a Boston University School of Public Health community discussion about COVID-19. Students\, faculty and staff are invited to participate. Please click the link below for Zoom details. \n\n\nSTARTS:\n11:00 am on Tuesday\, April 21\, 2020\n\nENDS:\n12:00 pm on Tuesday\, April 21\, 2020\n\nLOCATION:\nZoom Meeting Online\n\nREGISTRATION:\nhttps://www.bu.edu/sph/news-events/community-events/zoom-meetings/\n\nCONTACT NAME:\nSPH Event\n\nCONTACT EMAIL:\nsphevent@bu.edu
URL:https://scienceinboston.com/event/covid-19-community-conversations-boston-university/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200421T110000
DTEND;TZID=America/New_York:20200421T120000
DTSTAMP:20260429T051024
CREATED:20200417T172405Z
LAST-MODIFIED:20200417T172405Z
UID:27458-1587466800-1587470400@scienceinboston.com
SUMMARY:COVID-19: Community Conversations - Boston University
DESCRIPTION:Join Dean Sandro Galea online for a Boston University School of Public Health community discussion about COVID-19. Students\, faculty and staff are invited to participate. Please click the link below for Zoom details. \n\n\nSTARTS:\n11:00 am on Tuesday\, April 21\, 2020\n\nENDS:\n12:00 pm on Tuesday\, April 21\, 2020\n\nLOCATION:\nZoom Meeting Online\n\nREGISTRATION:\nhttps://www.bu.edu/sph/news-events/community-events/zoom-meetings/\n\nCONTACT NAME:\nSPH Event\n\nCONTACT EMAIL:\nsphevent@bu.edu
URL:https://scienceinboston.com/event/covid-19-community-conversations-boston-university-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T120000
DTEND;TZID=America/Vancouver:20200421T130000
DTSTAMP:20260429T051024
CREATED:20200415T182656Z
LAST-MODIFIED:20200415T182656Z
UID:8709-1587470400-1587474000@scienceinboston.com
SUMMARY:Special LINUS Report: Major Updates on Scientific Progress Amidst a Global Pandemic
DESCRIPTION:Having embarked on a longitudinal study to understand the impact of Coronavirus across life sciences\, we have identified four phases for how the pandemic will cause disruptions to the industry. Now\, with a second major data-collection time point\, and over 2\,000 respondents\, we have found major updates on what the life science community is thinking\, feeling and doing as coronavirus continues to affect our realities and shapes productivity. In this next wave of our research\, we will reveal the magnitude of the disruption to productivity\, the progress of workplace transitions\, and the developing sentiment felt across the industry.
URL:https://scienceinboston.com/event/special-linus-report-major-updates-on-scientific-progress-amidst-a-global-pandemic/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T120000
DTEND;TZID=America/Vancouver:20200421T130000
DTSTAMP:20260429T051024
CREATED:20200415T182656Z
LAST-MODIFIED:20200415T182656Z
UID:27453-1587470400-1587474000@scienceinboston.com
SUMMARY:Special LINUS Report: Major Updates on Scientific Progress Amidst a Global Pandemic
DESCRIPTION:Having embarked on a longitudinal study to understand the impact of Coronavirus across life sciences\, we have identified four phases for how the pandemic will cause disruptions to the industry. Now\, with a second major data-collection time point\, and over 2\,000 respondents\, we have found major updates on what the life science community is thinking\, feeling and doing as coronavirus continues to affect our realities and shapes productivity. In this next wave of our research\, we will reveal the magnitude of the disruption to productivity\, the progress of workplace transitions\, and the developing sentiment felt across the industry.
URL:https://scienceinboston.com/event/special-linus-report-major-updates-on-scientific-progress-amidst-a-global-pandemic-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200421T130000
DTEND;TZID=America/New_York:20200421T140000
DTSTAMP:20260429T051024
CREATED:20200330T175726Z
LAST-MODIFIED:20200330T175726Z
UID:8572-1587474000-1587477600@scienceinboston.com
SUMMARY:Vascular Specification and Development
DESCRIPTION:An online mini-symposium featuring four presentations: Renal stromal netrin-1 signaling drives kidney arterial development (Xiaowu Gu\, UT Southwestern) Inhibition of Notch signaling in pericytes leads to AVM-like lesions (Taliha Nadeem\, University of Illinois\, Chicago) Dach1 Promotes Coronary Artery Endothelial Cell Specification (Brian Raftrey\, Stanford University) Pro-angiogenic properties of Purified Exosome Product (PEP) (Ao Shi\, Mayo Clinic) The session will be moderated by Kayla Bayless\, Texas A&M University
URL:https://scienceinboston.com/event/vascular-specification-and-development/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200421T130000
DTEND;TZID=America/New_York:20200421T140000
DTSTAMP:20260429T051024
CREATED:20200330T175726Z
LAST-MODIFIED:20200330T175726Z
UID:27445-1587474000-1587477600@scienceinboston.com
SUMMARY:Vascular Specification and Development
DESCRIPTION:An online mini-symposium featuring four presentations: Renal stromal netrin-1 signaling drives kidney arterial development (Xiaowu Gu\, UT Southwestern) Inhibition of Notch signaling in pericytes leads to AVM-like lesions (Taliha Nadeem\, University of Illinois\, Chicago) Dach1 Promotes Coronary Artery Endothelial Cell Specification (Brian Raftrey\, Stanford University) Pro-angiogenic properties of Purified Exosome Product (PEP) (Ao Shi\, Mayo Clinic) The session will be moderated by Kayla Bayless\, Texas A&M University
URL:https://scienceinboston.com/event/vascular-specification-and-development-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T133000
DTEND;TZID=America/Vancouver:20200421T143000
DTSTAMP:20260429T051024
CREATED:20200420T211951Z
LAST-MODIFIED:20200420T211951Z
UID:8794-1587475800-1587479400@scienceinboston.com
SUMMARY:Innovation and Biotech in the Time of COVID-19: View from the Frontlines
DESCRIPTION:This three-part webinar series will feature biotech industry leaders\, experts\, and entrepreneurs discussing COVID-19 and its impact on innovation. \nIn our third panel\, hear from front-line workers. They’ll detail what they’re facing and how the biotech community can help. \nSpeakers include: \nRichard Malley\, Senior Physician in Medicine\, Division of Infectious Diseases\, Boston Children’s Hospital & Scientific Founder of Affinivax \nRick Malley\, M.D.\, began his education at the Ecole Active Bilingue in Paris\, France\, getting his Baccalaureate in 1982. He received his B.A. from Yale University\, his M.D. from Tufts University in 1990\, and pediatric infectious diseases and emergency medicine training at Boston Children’s Hospital. In 1997\, a chance meeting with Dr. Porter Anderson (one of the co-inventors of the Haemophilus influenzae type b conjugate vaccine) led to his interest in the development of a species-specific pneumococcal vaccine for use in developing countries and vaccinology in general. Under Dr. Anderson’s mentorship\, he shifted his research to the development of novel vaccines against pneumococcus and other pathogens\, leading to numerous scientific publications describing various aspects of pneumococcal pathogenesis and prevention\, such as acquired and innate immunity\, correlates of protection\, and mechanisms of protection from nasopharyngeal colonization. \nDr. Malley is the Kenneth McIntosh Chair in Pediatric Infectious Diseases at Boston Children’s Hospital and Professor of Pediatrics at Harvard Medical School. Dr. Malley regularly attends on the Pediatric Infectious Diseases service at Boston Children’s Hospital\, providing consultation on inpatients. He is also the Director of the Travel and Geographic Medicine Clinic\, providing advice\, vaccines and medications to both adult and pediatric travelers. \nDr. Malley runs a research laboratory with past and present funding from the Meningitis Research Foundation\, NIH\, PATH and the Bill and Melinda Gates Foundation (BMGF)\, focusing on vaccine development for pneumococcus\, Staphylococcus aureus\, Salmonella typhi and paratyphi\, and Mycobacterium tuberculosis and more recently SARS-CoV-2. In collaboration with PATH and the BMGF\, Dr. Malley led an international effort for the development of a a pneumococcal vaccine for developing countries. In 2014\, Dr. Malley and collaborators started Affinivax\, a biotechnology company seed-funded by BMGF and based on a novel technology called MAPS (Multiple Antigen Presenting System) to develop vaccines for developing countries. Streptococcus pneumoniae is the lead target being developed at Affinivax. A pneumococcal MAPS vaccine is currently in Phase 2 clinical testing in older adults. \nJoshua Resnick\, Physician at the Department of Emergency Medicine at Massachusetts General Hospital and Managing Director at RA Capital Management \nJosh Resnick is a Managing Director at RA Capital Management. Josh’s primary responsibility at RA Capital is to lead early-stage private investments in and oversee the creation of new companies developing drugs\, medical devices\, diagnostics\, and research tools. Josh holds a BA in Chemistry from Williams College\, an MD from the University of Pennsylvania School of Medicine\, and an MBA from the Wharton School of Business. He has more than 15 years of experience in investing\, company formation\, and company leadership across all stages of drug development\, from discovery through commercialization. Josh was previously co-lead of SV Health Investors’ US Biotech practice where he was responsible for SV’s US venture creation activities\, including its incubator\, Brahma Discovery. Before SV\, Josh was President and Managing Partner at MRL Ventures Fund\, the early-stage therapeutics-focused corporate venture fund within Merck & Co. Prior to MRL Ventures\, Josh was a Venture Partner with Atlas Venture and a Partner at Prism Venture Partners\, focusing on company formation and seed and Series A investing. Josh is currently a faculty member at Harvard Medical School and continues to practice medicine as an attending physician in the Department of Emergency Medicine at Massachusetts General Hospital \nHannu Rajaniemi\, Co-Founder and CEO of HelixNano \nHannu Rajaniemi is a co-founder and CEO of HelixNano\, a venture- and Y Combinator backed biotech startup. HelixNano’s ultimate mission is to build technologies that unlock a future where freedom from cancer is a fundamental human right. But right now\, the fight against a global pandemic needs all scientific hands on deck. In response to this existential challenge\, the team is applying its expertise to deploy a novel vaccination approach against COVID-19. \nHannu was born in Finland. At the age of eight he approached the European Space Agency with a fusion-powered spaceship design\, which was received with a polite “thank you” note. Hannu studied mathematics and theoretical physics at University of Oulu and Cambridge and holds a PhD in string theory from the University of Edinburgh. He co-founded a mathematics consultancy whose clients included UK Ministry of Defence and the European Space Agency. \nHannu is the author of four novels including The Quantum Thief (winner of 2012 Tähtivaeltaja Award for the best science fiction novel published in Finland and translated into more than 20 languages). His most recent book is Summerland (June 2018)\, an alternate history spy thriller in a world where the afterlife is real. His short fiction has been featured in Nature\, Slate\, MIT Technology Review and The New York Times. \nHannu lives in the San Francisco Bay Area with his wife\, neuroscientist Zuzana Krejciova-Rajaniemi\, and their vizsla puppy Neo. \nWe hope to help you see a few steps further into the future and enjoy some realistic optimism for the next few months! \nOur webinar will be hosted on YouTube Live. Registrants will receive the link in an email shortly before broadcast. \nContact emulcahy@labcentral.org with questions.
URL:https://scienceinboston.com/event/innovation-and-biotech-in-the-time-of-covid-19-view-from-the-frontlines/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/04/Innovation-and-Biotech-in-the-Time-of-COVID-19.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200421T133000
DTEND;TZID=America/Vancouver:20200421T143000
DTSTAMP:20260429T051024
CREATED:20200420T211951Z
LAST-MODIFIED:20200420T211951Z
UID:27469-1587475800-1587479400@scienceinboston.com
SUMMARY:Innovation and Biotech in the Time of COVID-19: View from the Frontlines
DESCRIPTION:This three-part webinar series will feature biotech industry leaders\, experts\, and entrepreneurs discussing COVID-19 and its impact on innovation. \nIn our third panel\, hear from front-line workers. They’ll detail what they’re facing and how the biotech community can help. \nSpeakers include: \nRichard Malley\, Senior Physician in Medicine\, Division of Infectious Diseases\, Boston Children’s Hospital & Scientific Founder of Affinivax \nRick Malley\, M.D.\, began his education at the Ecole Active Bilingue in Paris\, France\, getting his Baccalaureate in 1982. He received his B.A. from Yale University\, his M.D. from Tufts University in 1990\, and pediatric infectious diseases and emergency medicine training at Boston Children’s Hospital. In 1997\, a chance meeting with Dr. Porter Anderson (one of the co-inventors of the Haemophilus influenzae type b conjugate vaccine) led to his interest in the development of a species-specific pneumococcal vaccine for use in developing countries and vaccinology in general. Under Dr. Anderson’s mentorship\, he shifted his research to the development of novel vaccines against pneumococcus and other pathogens\, leading to numerous scientific publications describing various aspects of pneumococcal pathogenesis and prevention\, such as acquired and innate immunity\, correlates of protection\, and mechanisms of protection from nasopharyngeal colonization. \nDr. Malley is the Kenneth McIntosh Chair in Pediatric Infectious Diseases at Boston Children’s Hospital and Professor of Pediatrics at Harvard Medical School. Dr. Malley regularly attends on the Pediatric Infectious Diseases service at Boston Children’s Hospital\, providing consultation on inpatients. He is also the Director of the Travel and Geographic Medicine Clinic\, providing advice\, vaccines and medications to both adult and pediatric travelers. \nDr. Malley runs a research laboratory with past and present funding from the Meningitis Research Foundation\, NIH\, PATH and the Bill and Melinda Gates Foundation (BMGF)\, focusing on vaccine development for pneumococcus\, Staphylococcus aureus\, Salmonella typhi and paratyphi\, and Mycobacterium tuberculosis and more recently SARS-CoV-2. In collaboration with PATH and the BMGF\, Dr. Malley led an international effort for the development of a a pneumococcal vaccine for developing countries. In 2014\, Dr. Malley and collaborators started Affinivax\, a biotechnology company seed-funded by BMGF and based on a novel technology called MAPS (Multiple Antigen Presenting System) to develop vaccines for developing countries. Streptococcus pneumoniae is the lead target being developed at Affinivax. A pneumococcal MAPS vaccine is currently in Phase 2 clinical testing in older adults. \nJoshua Resnick\, Physician at the Department of Emergency Medicine at Massachusetts General Hospital and Managing Director at RA Capital Management \nJosh Resnick is a Managing Director at RA Capital Management. Josh’s primary responsibility at RA Capital is to lead early-stage private investments in and oversee the creation of new companies developing drugs\, medical devices\, diagnostics\, and research tools. Josh holds a BA in Chemistry from Williams College\, an MD from the University of Pennsylvania School of Medicine\, and an MBA from the Wharton School of Business. He has more than 15 years of experience in investing\, company formation\, and company leadership across all stages of drug development\, from discovery through commercialization. Josh was previously co-lead of SV Health Investors’ US Biotech practice where he was responsible for SV’s US venture creation activities\, including its incubator\, Brahma Discovery. Before SV\, Josh was President and Managing Partner at MRL Ventures Fund\, the early-stage therapeutics-focused corporate venture fund within Merck & Co. Prior to MRL Ventures\, Josh was a Venture Partner with Atlas Venture and a Partner at Prism Venture Partners\, focusing on company formation and seed and Series A investing. Josh is currently a faculty member at Harvard Medical School and continues to practice medicine as an attending physician in the Department of Emergency Medicine at Massachusetts General Hospital \nHannu Rajaniemi\, Co-Founder and CEO of HelixNano \nHannu Rajaniemi is a co-founder and CEO of HelixNano\, a venture- and Y Combinator backed biotech startup. HelixNano’s ultimate mission is to build technologies that unlock a future where freedom from cancer is a fundamental human right. But right now\, the fight against a global pandemic needs all scientific hands on deck. In response to this existential challenge\, the team is applying its expertise to deploy a novel vaccination approach against COVID-19. \nHannu was born in Finland. At the age of eight he approached the European Space Agency with a fusion-powered spaceship design\, which was received with a polite “thank you” note. Hannu studied mathematics and theoretical physics at University of Oulu and Cambridge and holds a PhD in string theory from the University of Edinburgh. He co-founded a mathematics consultancy whose clients included UK Ministry of Defence and the European Space Agency. \nHannu is the author of four novels including The Quantum Thief (winner of 2012 Tähtivaeltaja Award for the best science fiction novel published in Finland and translated into more than 20 languages). His most recent book is Summerland (June 2018)\, an alternate history spy thriller in a world where the afterlife is real. His short fiction has been featured in Nature\, Slate\, MIT Technology Review and The New York Times. \nHannu lives in the San Francisco Bay Area with his wife\, neuroscientist Zuzana Krejciova-Rajaniemi\, and their vizsla puppy Neo. \nWe hope to help you see a few steps further into the future and enjoy some realistic optimism for the next few months! \nOur webinar will be hosted on YouTube Live. Registrants will receive the link in an email shortly before broadcast. \nContact emulcahy@labcentral.org with questions.
URL:https://scienceinboston.com/event/innovation-and-biotech-in-the-time-of-covid-19-view-from-the-frontlines-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/04/Innovation-and-Biotech-in-the-Time-of-COVID-19.jpg
END:VEVENT
END:VCALENDAR